ACET - Adicet Bio, Inc.
7.57
0.550 7.266%
Share volume: 135,962
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$7.02
0.55
0.08%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-06-2024 | 03-06-2025 | 05-06-2025 | 08-07-2025 | 11-05-2025 | |
| Assets | ||||||||
| Total Assets | 293.095 M | 268.842 M | 245.962 M | 220.219 M | 191.271 M | 162.972 M | 140.479 M | |
| Current Assets | 250.350 M | 228.353 M | 206.316 M | 180.136 M | 153.563 M | 127.740 M | 106.494 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 96.583 M | 119.808 M | 122.306 M | 90.243 M | 73.999 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 247.589 M | 224.069 M | 105.482 M | 56.495 M | 28.133 M | 34.720 M | 29.099 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 25.407 M | 24.041 M | 24.088 M | 22.524 M | 21.108 M | 19.549 M | 17.994 M | |
| Other Assets | 17.338 M | 16.448 M | 15.558 M | 17.559 M | 16.600 M | 15.683 M | 15.991 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 293.095 M | 268.842 M | 245.962 M | 220.219 M | 191.271 M | 162.972 M | 140.479 M | |
| Total liabilities | 34.291 M | 33.731 M | 34.431 M | 33.610 M | 29.825 M | 29.600 M | 31.337 M | |
| Total current liabilities | 17.461 M | 17.904 M | 19.394 M | 19.392 M | 16.447 M | 17.079 M | 18.941 M | |
| Accounts Payable | 2.542 M | 1.899 M | 2.500 M | 4.830 M | 4.403 M | 3.292 M | 4.287 M | |
| Other liabilities | 16.830 M | 15.827 M | 15.037 M | 14.218 M | 13.378 M | 12.521 M | 11.770 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 16.830 M | 15.827 M | 15.037 M | 14.218 M | 13.378 M | 12.521 M | 11.770 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 258.804 M | 235.111 M | 211.531 M | 186.609 M | 161.446 M | 133.372 M | 109.142 M | |
| Common stock | 667.592 M | 673.800 M | 680.577 M | 684.487 M | 687.563 M | 690.738 M | 693.267 M | |
| Retained earnings | -408.788 M | -438.689 M | -469.167 M | -497.894 M | -526.108 M | -557.325 M | -584.181 M |